Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Teriparatide
PTH(1-34) | Bone-Building Anabolic Peptide
Teriparatide binds to PTH type 1 receptors (G-protein coupled receptors) on osteoblasts, osteocytes, and renal tubular cells. This activates PKA and PKC signaling pathways that promote osteoblast activity.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take BPC-157 with Teriparatide?
Yes, BPC-157 and Teriparatide can generally be taken together. Different mechanisms; no known interactions.
Is BPC-157 and Teriparatide safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between BPC-157 and Teriparatide?
Different mechanisms; no known interactions. This assessment has 90% confidence and is based on documented research data.
How should I time BPC-157 and Teriparatide?
BPC-157 has a half-life of <30 minutes and Teriparatide has a half-life of ~1 hour (subcutaneous); ~5 minutes (intravenous). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.